BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2022
View Archived Issues
Preprints age well, manuscript preprint shows
Read More
New DNA intercalator/topo II inhibitor shows improved anticancer activity over doxorubicin
Read More
Prodrug form target of JBP-485 and vitamin E developed to treat NASH
Read More
GMQ-3 shows promising efficacy in models of lung cancer
Read More
Discovery of novel BU-4664L derivatives with potential anticancer activity
Read More
Medshine Discovery patents new GLP-1 receptor agonists
Read More
Chinese researchers disclose SOS1 inhibitors
Read More
Betta Pharmaceuticals divulges new PTPN11 inhibitors
Read More
Roche presents compounds for Gram-negative bacterial infections
Read More
Mission Therapeutics synthesizes USP30 inhibitors
Read More
Novel halogenated phenoxychalcones described with activity in breast cancer cell lines
Read More
Siglec-15 promotes osteosarcoma tumor progression
Read More
Inhaled remdesivir shows efficacy in nonhuman primate model of SARS-CoV-2 infection
Read More
VC-2 vaccine confers protection against viral ocular immunopathogenesis through T-cell infiltration
Read More